HoldingsChannel.com
| Entity | Amount | Change
03/31/2023 to 06/30/2023 |
Position Size ($ in 1000's) |
|---|---|---|---|
 ImmunoGen Inc |
1,420,000 | +141,800 | $26,795 |
| IMGN | 1,420,000 | +1,270,000 | $26,795 |
 Akero Therapeutics Inc |
$22,309 | ||
| AKRO | 241,357 | +38,796 | $11,269 |
| Call | 236,500 | +236,500 | $11,040 |
| Merus NV |
589,255 | -79,529 | $15,515 |
| MRUS | 589,255 | -79,529 | $15,515 |
| Morphic Holding Inc |
252,309 | +200,625 | $14,465 |
| MORF | 252,309 | +200,625 | $14,465 |
| Schrodinger Inc |
286,169 | +73,344 | $14,286 |
| SDGR | 286,169 | +73,344 | $14,286 |
| Krystal Biotech Inc |
118,941 | +84,927 | $13,964 |
| KRYS | 118,941 | +84,927 | $13,964 |
| Intra Cellular Therapies Inc |
198,723 | +73,688 | $12,583 |
| ITCI | 198,723 | +73,688 | $12,583 |
| Oric Pharmaceuticals Inc |
1,450,822 | +14,877 | $11,258 |
| ORIC | 1,450,822 | +14,877 | $11,258 |
| MoonLake Immunotherapeutics |
200,000 | +94,250 | $10,200 |
| MLTX | 200,000 | +94,250 | $10,200 |
| Aclaris Therapeutics Inc |
$9,028 | ||
| Call | 651,400 | UNCH | $6,755 |
| ACRS | 219,229 | -871 | $2,273 |
| Mirati Therapeutics Inc |
$8,716 | ||
| Call | 150,000 | +150,000 | $5,420 |
| MRTX | 91,213 | +91,213 | $3,296 |
| Biogen Idec Inc |
26,854 | +15,543 | $7,649 |
| BIIB | 26,854 | +15,543 | $7,649 |
| 89bio Inc |
396,497 | -241,718 | $7,514 |
| ETNB | 396,497 | -41,718 | $7,514 |
| Cogent Biosciences Inc |
620,000 | +40,736 | $7,341 |
| COGT | 620,000 | +40,736 | $7,341 |
| Mersana Therapeutics Inc |
$6,909 | ||
| Call | 1,100,000 | +1,100,000 | $3,619 |
| MRSN | 1,000,000 | +459,941 | $3,290 |
| United Therapeutics Corp |
30,029 | +11,451 | $6,629 |
| UTHR | 30,029 | +11,451 | $6,629 |
| MacroGenics Inc |
1,215,675 | -146,134 | $6,504 |
| MGNX | 1,215,675 | -146,134 | $6,504 |
| KalVista Pharmaceuticals Inc |
720,508 | -3,036 | $6,485 |
| KALV | 720,508 | -3,036 | $6,485 |
| Veracyte Inc |
229,451 | +19,798 | $5,844 |
| VCYT | 229,451 | +19,798 | $5,844 |
| BioCryst Pharmaceuticals Inc |
760,904 | +183,147 | $5,357 |
| BCRX | 760,904 | +183,147 | $5,357 |
| Terns Pharmaceuticals Inc |
599,668 | -68,254 | $5,247 |
| TERN | 599,668 | -68,254 | $5,247 |
| Poseida Therapeutics Inc |
2,945,948 | +256,647 | $5,185 |
| PSTX | 2,945,948 | +256,647 | $5,185 |
| Nuvalent Inc |
115,067 | -166,466 | $4,852 |
| NUVL | 115,067 | -166,466 | $4,852 |
| Gilead Sciences Inc |
60,448 | +318 | $4,659 |
| GILD | 60,448 | +318 | $4,659 |
| Vertex Pharmaceuticals Inc |
13,175 | -6 | $4,636 |
| VRTX | 13,175 | -6 | $4,636 |
| Tela Bio Inc |
416,440 | +362,344 | $4,219 |
| TELA | 416,440 | +362,344 | $4,219 |
| Viking Therapeutics Inc |
258,595 | -121,405 | $4,192 |
| VKTX | 258,595 | -121,405 | $4,192 |
| Praxis Precision Medicines Inc |
3,476,162 | +3,476,162 | $3,998 |
| PRAX | 3,476,162 | +3,476,162 | $3,998 |
| Xenon Pharmaceuticals Inc |
99,756 | +3,113 | $3,841 |
| XENE | 99,756 | +3,113 | $3,841 |
| Olema Pharmaceuticals Inc |
390,466 | +390,466 | $3,526 |
| OLMA | 390,466 | +390,466 | $3,526 |
| Sarepta Therapeutics Inc |
29,860 | +20,590 | $3,420 |
| SRPT | 29,860 | +20,590 | $3,420 |
| Prothena Corporation PLC |
49,721 | +49,721 | $3,395 |
| PRTA | 49,721 | +49,721 | $3,395 |
| Insmed Inc |
144,464 | +670 | $3,048 |
| INSM | 144,464 | +670 | $3,048 |
| Pharvaris NV |
200,000 | -359,387 | $3,028 |
| PHVS | 200,000 | -359,387 | $3,028 |
| ANI Pharmaceuticals Inc |
54,041 | +54,041 | $2,909 |
| ANIP | 54,041 | +54,041 | $2,909 |
| Phathom Pharmaceuticals Inc |
200,000 | UNCH | $2,864 |
| PHAT | 200,000 | UNCH | $2,864 |
| Cerus Corp |
1,158,265 | +5,363 | $2,849 |
| CERS | 1,158,265 | +5,363 | $2,849 |
| Mirum Pharmaceuticals Inc |
106,375 | +436 | $2,752 |
| MIRM | 106,375 | +436 | $2,752 |
| Incyte Corp |
34,110 | +172 | $2,123 |
| INCY | 34,110 | +172 | $2,123 |
| Trevi Therapeutics Inc |
885,924 | UNCH | $2,117 |
| TRVI | 885,924 | UNCH | $2,117 |
| Intellia Therapeutics Inc |
50,858 | +13,000 | $2,074 |
| NTLA | 50,858 | +13,000 | $2,074 |
| Pliant Therapeutics Inc |
107,267 | -192,333 | $1,944 |
| PLRX | 107,267 | +7,267 | $1,944 |
| Rhythm Pharmaceuticals Inc |
116,168 | +116,168 | $1,916 |
| RYTM | 116,168 | +116,168 | $1,916 |
| CymaBay Therapeutics Inc |
160,000 | +160,000 | $1,752 |
| CBAY | 160,000 | +160,000 | $1,752 |
| Ambrx Biopharma Inc |
100,000 | +100,000 | $1,646 |
| AMAM | 100,000 | +100,000 | $1,646 |
| Cue Biopharma Inc |
403,402 | +97,124 | $1,472 |
| CUE | 403,402 | +97,124 | $1,472 |
| Eliem Therapeutics Inc |
494,089 | +8,134 | $1,383 |
| ELYM | 494,089 | +8,134 | $1,383 |
| Annexon Inc |
389,911 | +389,911 | $1,372 |
| ANNX | 389,911 | +389,911 | $1,372 |
| Zura Bio Ltd |
160,000 | +160,000 | $1,312 |
| ZURA | 160,000 | +160,000 | $1,312 |
| Reata Pharmaceuticals Inc |
12,500 | +12,500 | $1,274 |
| RETA | 12,500 | +12,500 | $1,274 |
See Full List: All Stocks Held By Silverarc Capital Management LLC
— Including:
• Biggest new positions
• Biggest exits
• Biggest increased positions
• Biggest decreased positions
See Details: Top 10 Stocks Held By Silverarc Capital Management LLC
|
Size ($ in 1000's)
At 06/30/2023: $323,278 At 03/31/2023: $242,257 Combined Holding Report Includes:
Silverarc Capital Management LLC holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Silverarc Capital Management LLC 13F filings. Link to 13F filings: SEC filings |
